oscar virtual primary care :: Article Creator Oscar To Offer Free Virtual Primary Care Visits - Becker's Hospital ... The free virtual primary care benefit includes unlimited virtual visits with Oscar primary care providers, and will be offered to members with individual and family plans. Oscar Primary Care will also offer some members $0 at-home vital monitors and in-home lab draws when ordered by an Oscar primary care provider. The virtual primary care benefit will be launched in 10 markets across Florida, Texas, California, Colorado and New York, pending regulatory approval. In addition, Oscar will expand to 19 states and 47 markets in 2021. This includes four new states — Arkansas, North Carolina, Oklahoma and Iowa — plus 19 new markets. Read more here. More articles on payers:Anthem agrees to pay $27K medical bill after TV report airsLeapfrog Group: Employers rank Cigna highest, UnitedHealthcare lowest on drive for valueAnthem doub...
Get link
Facebook
X
Pinterest
Email
Other Apps
US sinks another $2.1 billion into a potential vaccine - ABC News
Get link
Facebook
X
Pinterest
Email
Other Apps
-
Pharma giants GlaxoSmithKline and Sanofi Pasteur say they will supply 100 million doses of an experimental COVID-19 vaccine to the United States as governments buy up supplies in hopes of securing a candidate that works
By
DANICA KRKA Associated Press
July 31, 2020, 4:47 PM
3 min read
LONDON -- Pharma giants GlaxoSmithKline and Sanofi Pasteur have announced they will supply 100 million doses of an experimental COVID-19 vaccine to the United States as governments buy up supplies in hopes of securing a candidate that works.
The United States will pay up to $2.1 billion “for development including clinical trials, manufacturing, scale-up and delivery" of the vaccine, the two companies based in Europe said in a statement. Sanofi will get the bulk of the funds.
The U.S. government has a further option for the supply of an additional 500 million doses longer term as part of its Operation Warp Speed program.
“The portfolio of vaccines being assembled for Operation Warp Speed increases the odds that we will have at least one safe, effective vaccine as soon as the end of this year,” U.S. Health and Human Services Secretary Alex Azar said in a statement. “Today’s investment supports the Sanofi and GSK adjuvanted product all the way through clinical trials and manufacturing, with the potential to bring hundreds of millions of safe and effective doses to the American people.”
Earlier this week the British government signed a deal for 60 million doses of a potential coronavirus vaccine that could start to be rolled out in the first half of next year.
The vaccine being developed by Britain's GSK and France’s Sanofi’s is based on existing DNA-based technology that is used to produce Sanofi’s seasonal flu vaccine. It is one of several vaccines in development.
“The global need for a vaccine to help prevent COVID-19 is massive, and no single vaccine or company will be able to meet the global demand alone,” said Thomas Triomphe, executive vice president of Sanofi Pasteur.
The executive arm of the European Union issued a statement later Friday saying it had concluded exploratory talks with Sanofi to “provide for an option for all EU member states to purchase the vaccine.'' The idea would be to offer a contractual framework for the purchase of 300 million doses should the vaccine work.
“We are in advanced discussions with several other companies,'' European Commission President Ursula von der Leyen said. “While we do not know today which vaccine will work best in the end, Europe is investing in a diversified portfolio of promising vaccines, based on various types of technologies. This increases our chances to obtain rapidly an effective remedy against the virus.''
———
Associated Press Writer Samuel Petrequin in Brussels contributed
——
Follow AP’s pandemic coverage at https://ift.tt/2xPjH8c and https://ift.tt/2wrCaXK
prepmod vaccine :: Article Creator What Went Wrong With The 'Tiny Nonprofit' Behind The State's Beleaguered Vaccine Site When Gov. Charlie Baker released vaccine eligibility to a million more Massachusetts residents last week, state websites crumpled under a virtual stampede of people rushing to secure appointments. Users were left in online limbo for hours, and many gaped at how something so critical could be entrusted to, in their eyes, flimsy web services and fragile program designs. "Foolish system. Ill-Designed. Who are the people that designed it?" seethed Steve Rosenfeld, 70, from Worcester in a written comment to WBUR after he failed to get an appointment. The nonprofit Maryland Partnership for Prevention runs one of the crucial websites that crashed last week, a service it provides in more than two dozen states across the country. The company's software allows people to register their COVID-19 vaccines and make a...
arthritis osteoporosis and rheumatology associates :: Article Creator Arthritis & Rheumatology Clinic Contact Information Arthritis & Rheumatology Clinic 740 Jordan Street, Shreveport, LA 71101 Office: (318) 424-9240 Fax: (318) 424-0022 www.Arthdoc.Com Find us on Facebook About Dr. Goodman Robert E. Goodman, M.D. Board-Certified Rheumatologist "Blending the most innovative approaches in rheumatology and arthritis treatments with personalized patient care" Board Certified Rheumatologist Robert E. Goodman, M.D., of the Arthritis and Rheumatology Clinic in Shreveport, has been caring for patients in the Ark-La-Tex since 1985. Dr. Goodman combines his specialized training and experience with personalized care to provide patients with leading-edge technology and the latest treatment options. Dr. Goodman and the Arthritis & Rheumatology Clinic Healthcare Team of caring, compassionate healthcare professiona...
Comments
Post a Comment